You are here

  • Home
  • Archive
  • Volume 93, Issue Suppl 2
  • RESPIRATORY SYNCYTIAL VIRUS SYNAGIS VACCINE, ITS EFFICACY IN REDUCING INFANT ADMISSIONS WITH RESPIRATORY SYNCYTIAL VIRUS-POSITIVE BRONCHIOLITIS IN PREMATURE BABIES (⩽30 WEEKS): SHOULD WE VACCINATE MORE BABIES?

Article info

Article menu
Poster walk sessions
Nursing: science and technology
RESPIRATORY SYNCYTIAL VIRUS SYNAGIS VACCINE, ITS EFFICACY IN REDUCING INFANT ADMISSIONS WITH RESPIRATORY SYNCYTIAL VIRUS-POSITIVE BRONCHIOLITIS IN PREMATURE BABIES (⩽30 WEEKS): SHOULD WE VACCINATE MORE BABIES?

Authors

Citation

Barsoum ZB, Sheridan M, Kutty M
RESPIRATORY SYNCYTIAL VIRUS SYNAGIS VACCINE, ITS EFFICACY IN REDUCING INFANT ADMISSIONS WITH RESPIRATORY SYNCYTIAL VIRUS-POSITIVE BRONCHIOLITIS IN PREMATURE BABIES (⩽30 WEEKS): SHOULD WE VACCINATE MORE BABIES?
Archives of Disease in Childhood 2008;93:pw604.

Publication history

  • First published September 30, 2015.
Online issue publication 
March 22, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

2008 BMJ Publishing Group & Royal College of Paediatrics and Child Health